Table 1.
Key Results From the 2007 National Practice Benchmark
| Benchmark | Median | Average | Count |
|---|---|---|---|
| New patients per FTE hem onc | 308.41 | 361.01 | 45 |
| Revenue per FTE hem onc | $3,632,141 | $4,159,702 | 84 |
| Chemotherapy administrations per FTE staff in department per year | 711 | 791 | 67 |
| Drug revenue per FTE hem onc | $2,485,294 | $2,818,580 | 78 |
| Drug cost per FTE hem onc | $2,000,397 | $2,019,970 | 66 |
| Drug margin per total revenue | 11.4% | 12.3% | 65 |
| Drug cost per total cost | 67.4% | 63.2% | 75 |
| FTE staff per FTE physician | 6.1 | 7.6 | 98 |
| Revenue per new patient | $11,895 | $11,645 | 58 |
| E & M revenue per FTE physician | $297,811 | $329,531 | 67 |
| Drug margin per FTE hem onc | $466,136 | $525,596 | 54 |
Abbreviations: Count, number of responses to each particular data point in the survey; FTE, full-time equivalent; hem onc, hematology and oncology physician; E & M, evaluation and management.